A case of chronic myeloid leukemia with eosinophilic interstitial pneumonitis after administration of imatinib mesylate for 11 months

Int J Hematol. 2010 Dec;92(5):777-8. doi: 10.1007/s12185-010-0729-z. Epub 2010 Nov 26.

Authors

Koichiro Suemori, Hiroshi Fujiwara, Seiichiro Watanabe, Taichi Azuma, Masaki Yasukawa

PMID: 21110146
DOI: 10.1007/s12185-010-0729-z

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use
Benzamides
Female
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
Lung Diseases, Interstitial / complications*
Lung Diseases, Interstitial / diagnostic imaging
Lung Diseases, Interstitial / pathology
Piperazines / adverse effects
Piperazines / therapeutic use*
Pulmonary Eosinophilia / complications
Pulmonary Eosinophilia / diagnostic imaging
Pulmonary Eosinophilia / pathology
Pyrimidines / adverse effects
Pyrimidines / therapeutic use*
Radiography
Treatment Outcome

Substances

Antineoplastic Agents
Benzamides
Piperazines
Pyrimidines
Imatinib Mesylate